Australia is eagerly anticipating the arrival of retatrutide, a novel dual GIP and GLP-1 receptor agonist , representing a potential advance in weight loss . Early study data have demonstrated impressive results, https://giant-talon-mountain-bik272745.jasperwiki.com/8084138/retatrutide_in_australia_a_potential_breakthrough_for_reducing_body_weight